Skip to main content
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,227.00
-73.00 (-1.38%)
Apr 24, 2025, 5:24 PM IDT

TLV:TEVA Revenue

In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B USD with 4.40% growth. Teva Pharmaceutical Industries had revenue of $4.23B in the quarter ending December 31, 2024, a decrease of -5.12%.

Revenue
$16.54B
Revenue Growth
+4.40%
P/S Ratio
0.99
Revenue / Employee
$463.60K
Employees
35,686
Market Cap
59.80B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.77B
Kamada 586.24M
Bait Bakfar 103.40M
Novolog (Pharm-Up 1966) 2.02B
Ilex Medical 920.37M
BrainsWay 149.39M
SofWave Medical 217.27M
InterCure 272.67M
Revenue Rankings

Teva Pharmaceutical Industries News

More News